Identification of ANXA1 as a Lymphatic Metastasis and Poor Prognostic Factor in Pancreatic Ductal Adenocarcinoma |
Liu, Qing-Hua
(Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute)
Shi, Mei-Lin (Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute) Bai, Jin (Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute) Zheng, Jun-Nian (Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute) |
1 | Basu B, Correa de Sampaio P, Mohammed H, et al (2012). Inhibition of MT1-MMP activity using functional antibody fragments selected against its hemopexin domain. Int J Biochem Cell Biol, 44, 393-403. DOI |
2 | Blackwell GJ, Carnuccio R, Di Rosa M, et al (1980). Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids. Nature, 287, 147-9. DOI |
3 | Cao Y, Li Y, Edelweiss M, et al (2008). Loss of annexin A1 expression in breast cancer progression. Appl Immunohistochem Mol Morphol, 16, 530-4. DOI ScienceOn |
4 | Chakraborty A, Dutta J, Das S, et al (2013). Comparison of ex vivo cultivated human limbal epithelial stem cell viability and proliferation on different substrates. Int Ophthalmol, 33, 665-70. DOI |
5 | Chao YL, Shepard CR, Wells A (2010). Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer, 9, 179. DOI |
6 | Chen CY, Shen JQ, Wang F, Wan R, Wang XP (2012). Prognostic significance of annexin A1 expression in pancreatic ductal adenocarcinoma. Asian Pac J Cancer Prev, 13, 4707-12. DOI ScienceOn |
7 | Flower RJ, Blackwell GJ (1979). Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature, 278, 456-9. DOI |
8 | Hongsrichan N, Rucksaken R, Chamgramol Y, et al (2013). Annexin A1: A new immunohistological marker of cholangiocarcinoma. World J Gastroenterol, 19, 2456-65. DOI |
9 | Hynes RO (2003). Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both? Cell, 113, 821-3. DOI |
10 | Inokuchi J, Lau A, Tyson DR, et al (2009). Loss of annexin A1 disrupts normal prostate glandular structure by inducing autocrine IL-6 signaling. Carcinogenesis, 30, 1082-8. DOI |
11 | Kang JS, Calvo BF, Maygarden SJ, et al (2002). Dysregulation of annexin I protein expression in high-grade prostatic intraepithelial neoplasia and prostate cancer. Clin Cancer Res, 8, 117-23. |
12 | Keleg S, Buchler P, Ludwig R, et al (2003). Invasion and metastasis in pancreatic cancer. Mol Cancer, 2, 14. DOI |
13 | Li Y, Wen T, Zhu M, et al (2013). Glycoproteomic analysis of tissues from patients with colon cancer using lectin microarrays and nanoLC-MS/MS. Mol Biosyst, 9, 1877-87. DOI |
14 | Lim LH, Pervaiz S (2007). Annexin 1: the new face of an old molecule. FASEB J, 21, 968-75. DOI |
15 | Nan Y, Yang S, Tian Y, et al (2009). Analysis of the expression protein profiles of lung squamous carcinoma cell using shot-gun proteomics strategy. Med Oncol, 26, 215-21. DOI |
16 | Schittenhelm J, Trautmann K, Tabatabai G, et al (2009). Comparative analysis of annexin-1 in neuroepithelial tumors shows altered expression with the grade of malignancy but is not associated with survival. Mod Pathol, 22, 1600-11. DOI |
17 | Siegel R, Naishadham D, Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. DOI ScienceOn |
18 | Swa HL, Shaik AA, Lim LH, et al (2014). Mass spectrometry-based quantitative proteomics and integrative network analysis accentuates modulating roles of Annexin-1 in mammary tumorigenesis. Proteomics. |
19 | Wells A, Griffith L, Wells JZ, et al (2013). The dormancy dilemma: quiescence versus balanced proliferation. Cancer Res, 73, 3811-6. DOI |
20 | Yates C, Shepard CR, Papworth G, et al (2007). Novel three-dimensional organotypic liver bioreactor to directly visualize early events in metastatic progression. Adv Cancer Res, 97, 225-46. DOI |
21 | Yu G, Wang J, Chen Y, et al (2008). Tissue microarray analysis reveals strong clinical evidence for a close association between loss of annexin A1 expression and nodal metastasis in gastric cancer. Clin Exp Metastasis, 25, 695-702. DOI |
22 | Zeng GQ, Cheng AL, Tang J, et al (2013). Annexin A1: A new biomarker for predicting nasopharyngeal carcinoma response to radiotherapy. Med Hypotheses, 81, 68-70. DOI |